LON:GNS Genus (GNS) Share Price, News & Analysis GBX 1,846 +102.00 (+5.85%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range 1,749.45▼ 1,87050-Day Range 1,630▼ 1,90452-Week Range 1,478▼ 2,518Volume72,696 shsAverage Volume98,244 shsMarket Capitalization£1.22 billionP/E Ratio3,767.35Dividend Yield1.73%Price TargetGBX 2,150 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesStock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider Trades Get Genus alerts: Email Address Genus MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside16.5% UpsideGBX 2,150 Price TargetShort InterestN/ADividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.07Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.70 out of 5 stars 2.5 Analyst's Opinion Consensus RatingGenus has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageGenus has only been the subject of 1 research reports in the past 90 days.Read more about Genus' stock forecast and price target. Previous Next N/A Short Interest Short InterestThere is no current short interest data available for GNS. Previous Next 0.8 Dividend Strength Dividend YieldGenus pays a meaningful dividend of 1.73%, higher than the bottom 25% of all stocks that pay dividends.Dividend GrowthGenus does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Genus is 6,530.61%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about Genus' dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for GNS. Previous Next 1.7 News and Social Media Coverage News SentimentGenus has a news sentiment score of 0.07. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.62 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Genus this week, compared to 0 articles on an average week.Search InterestOnly 2 people have searched for GNS on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Genus insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.69% of the stock of Genus is held by insiders.Percentage Held by Institutions78.52% of the stock of Genus is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Genus' insider trading history. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Genus is 3,767.35, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 143.45.Price to Earnings Ratio vs. SectorThe P/E ratio of Genus is 3,767.35, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 164.48.Price to Earnings Growth RatioGenus has a PEG Ratio of 2.87. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioGenus has a P/B Ratio of 2.11. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Colonial MetalsCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.In answer to this issue, we have released a Special Report to the public. About Genus Stock (LON:GNS)Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands. In addition, it offers technical services to farmers. The company was incorporated in 1994 and is based in Basingstoke, the United Kingdom.Read More GNS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart GNS Stock News HeadlinesJuly 25 at 6:53 AM | finance.yahoo.comCalculating The Intrinsic Value Of Genus plc (LON:GNS)July 20, 2024 | markets.businessinsider.comGenus plc (GNS) Gets a Buy from Kepler CapitalJuly 26, 2024 | Porter & Company (Ad)Nvidia insiders dumping sharesAll the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.July 19, 2024 | msn.comFTSE 100 closes higher as defensive stocks offset inflation jittersJuly 19, 2024 | americanbankingnews.comGenus (LON:GNS) Shares Down 8.6% on Analyst DowngradeJuly 19, 2024 | americanbankingnews.comDeutsche Bank Aktiengesellschaft Lowers Genus (LON:GNS) Price Target to GBX 2,150May 7, 2024 | lse.co.ukLondon open: Stocks rally as investors mull retail sales, house pricesMay 3, 2024 | lse.co.ukLondon midday: Stocks extend gains as Anglo rallies; payrolls eyedJuly 26, 2024 | Porter & Company (Ad)Nvidia insiders dumping sharesAll the signs show the AI market is about to reverse. And unless you know what’s really going on in this sector, you could be wiped out. Inside this new expose, you'll discover exactly how the AI crisis will unfold... how you can prepare for it before it's too late... and how you can potentially profit from it, too. Click here to read the new expose, The Big AI Die-Up while you still can.April 22, 2024 | finance.yahoo.comWith 83% institutional ownership, Genus plc (LON:GNS) is a favorite amongst the big gunsApril 2, 2024 | msn.comFact Check: Video Claimed Scuba Diver Swam With Dinosaur. Here's the TruthMarch 14, 2024 | msn.comShould I buy the current dogs of the FTSE 250?February 25, 2024 | finance.yahoo.comGenus plc (LON:GNS) Just Reported Earnings, And Analysts Cut Their Target PriceFebruary 22, 2024 | lse.co.ukGenus touts programme to boost investment returns as profit declinesFebruary 22, 2024 | finance.yahoo.comGenus plc Reports Interim Results for the Six Months Ended 31 December 2023February 16, 2024 | finance.yahoo.comEstimating The Intrinsic Value Of Genus plc (LON:GNS)February 15, 2024 | lse.co.ukLondon midday: Stocks dip as investors mull GDP; airlines fly higherFebruary 14, 2024 | wsj.comGenus PLCSee More Headlines Receive GNS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Genus and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:GNS CUSIPN/A CIKN/A Webwww.genusplc.com Phone+44-1256-347100FaxN/AEmployees3,500Year FoundedN/APrice Target and Rating Average Stock Price TargetGBX 2,150 High Stock Price TargetGBX 2,150 Low Stock Price TargetGBX 2,150 Potential Upside/Downside+16.8%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)GBX 0.49 Trailing P/E Ratio3,755.21 Forward P/E Ratio21.07 P/E Growth2.87Net Income£33.40 million Net Margins4.96% Pretax MarginN/A Return on Equity5.27% Return on Assets3.18% Debt Debt-to-Equity Ratio50.99 Current Ratio2.15 Quick Ratio1.08 Sales & Book Value Annual Sales£673.10 million Price / Sales1.81 Cash FlowGBX 36.39 per share Price / Cash Flow50.56 Book ValueGBX 875 per share Price / Book2.10Miscellaneous Outstanding Shares66,030,000Free FloatN/AMarket Cap£1.21 billion OptionableNot Optionable Beta0.31 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMr. Jorgen Kokke (Age 56)Chief Executive Officer & Director Comp: $586.74kMs. Alison Jane Henriksen ACA (Age 57)CFO & Executive Director Comp: $605kDr. Matt CulbertsonChief Operating OfficerDr. Elena RiceHead of R&D and Chief Scientific OfficerMr. Daniel William David HartleyGroup General Counsel & Company SecretaryMs. Angelle R. RosataGroup Human Resources DirectorMr. Jerry ThompsonGlobal Head of Beef & AquaAndrew ThompsonHead of ABS EMEAMs. Janet DuaneGroup Financial ControllerMore ExecutivesKey CompetitorsBTGLON:BTGAbcamLON:ABCOxford Nanopore TechnologiesLON:ONTErgomedLON:ERGOSilence TherapeuticsLON:SLNView All CompetitorsInsidersStephen WilsonSold 5,241 sharesTotal: £11.23 M ($2,142.00/share)View All Insider Transactions GNS Stock Analysis - Frequently Asked Questions How have GNS shares performed this year? Genus' stock was trading at GBX 2,170 at the start of the year. Since then, GNS shares have decreased by 14.9% and is now trading at GBX 1,846. View the best growth stocks for 2024 here. How do I buy shares of Genus? Shares of GNS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. What other stocks do shareholders of Genus own? Based on aggregate information from My MarketBeat watchlists, some other companies that Genus investors own include Clinigen Group (CLIN), Glencore (GLEN), Tesco (TSCO), AstraZeneca (AZN), British American Tobacco (BATS), Cronos Group (CRON) and Dairy Crest Group (DCG). This page (LON:GNS) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genus plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Genus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNS Stock Alerts